Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple Myeloma
Status:
Completed
Trial end date:
2018-07-20
Target enrollment:
Participant gender:
Summary
This phase I/II trial studies the best dose and side effects of lenalidomide and thalidomide,
and how well they work with dexamethasone in treating participants with multiple myeloma that
has come back or does not respond to treatment. Drugs used in chemotherapy, such as
lenalidomide, thalidomide and dexamethasone, work in different ways to stop the growth of
tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them
from spreading.